Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
ANVS
#3492
Annovis Bio, Inc.
2.6
9
-2.54%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-2.54%
Monatliche Änderung
-9.12%
6 month change
+14.47%
Jahresänderung
+46.20%
Vorheriger Schlusskurs
2.7
6
Open
2.6
6
Bid
Ask
Low
2.6
6
High
2.6
9
Volumen
28
Märkte
Aktien
Gesundheitswesen
ANVS
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
13.8 M
19.49 M
19.49 M
19.49 M
26.5 M
—
Valuation ratios
Enterprise value
98.57 M
87.46 M
6.99 M
25.15 M
39.57 M
159.19 M
Price to earnings ratio
-1.71
-2.18
-0.74
-1.4
-1.74
-6.06
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-3.61
-2.81
-0.89
-1.31
-1.31
-6.32
Price to book ratio
-10.34
6.61
0.59
0.6
0.55
8.36
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.88
-0.42
-0.21
-0.29
-0.42
-1.34
Return on equity %
-1.79
-0.63
-0.23
-0.34
-0.55
-1.75
Return on invested capital %
7 128.56
—
-580.57
519.35
-2 240.34
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.38
2.83
9.03
6.26
4.2
22.32
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.28
-0.68
-0.46
-0.28
-0.18
-1.6
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.1
0.87
1.27
0.93
0.81
3.88
Net current asset value per share
1.12
0.9
1.3
0.95
0.83
3.98
Tangible book value per share
0.62
0.76
1.38
0.99
0.7
3.83
Working capital per share
0.65
0.58
1.15
0.8
0.63
3.17
Book value per share
0.62
0.76
1.38
0.99
0.7
3.83
Nachrichten
Annovis Bio startet Langzeitstudie für Parkinson-Wirkstoff Buntanetap ab Januar 2026
Annovis Bio to launch long-term Parkinson’s drug study in January
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops
Annovis Bio: Direktor Hoffman kauft Aktien im Wert von 193.794 US-Dollar
Annovis Bio director Hoffman buys $193,794 in shares
Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling
Annovis Bio: Direktor kauft Aktien für 69.900 US-Dollar nach starkem Kursanstieg
Annovis Bio director Hoffman buys $69.9k in ANVS stock
Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)
Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion
Annovis Bio raises $3.4 million in registered direct offering